Second-line treatment for status epilepticus: What’s the latest?

Most clinical guidelines provide little information on efficacy and safety to guide the choice of second-line therapy for status epilepticus. As a result, treatment choices may be driven as much by habit, training and tradition as by evidence. What do the latest data show about second-line treatment effectiveness, and how can research move forward?

Read about recent studies

More from Epigraph:

Post-ictal psychosis: Identification, treatment and prevention

After the wave subsides: Post-ictal effects

Hold the phone: Smartphone video improves diagnostic accuracy of epilepsy and psychogenic seizures, study says

Conquering the treatment gap: Pakistan starts small, stays flexible, and never gives up

Can seizure free mean medication free? The evidence, and a debate

Because of the GDPR, we have had to restrict our email distribution list, and we may no longer be able to reach everyone who may have an interest.  Please feel free to share this email with others who may be interested.

Subscribe to ILAE newsletters and Epigraph here